![week 7 semaglutide Efficacy and safety of once weekly 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial semaglutide [TUSOM | Pharmwiki]](https://www.thelancet.com/cms/10.1016/S2213-8587(23)00388-1/asset/ea6ce183-9bef-430d-8294-d1c4f42feac0/main.assets/gr2_lrg.jpg)
week 7 semaglutide
Shipping Estimate
week 7 semaglutide Efficacy and safety of once weekly 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial semaglutide [TUSOM | Pharmwiki]
USD21.13
USD62.13
Pay in 4 interest-free payments of $5.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
![week 7 semaglutide Efficacy and safety of once weekly 24 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial semaglutide [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1_semaglutide.png?w=800&tok=afc35c)
![week 7 semaglutide Efficacy and safety of once weekly 24 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial semaglutide [TUSOM | Pharmwiki]](https://cdn.thepharmaletter.com/convert/files/2024/04/007f22a0-0153-11ef-a588-e798d47e404e-wegovy_novo_big.png/r%5Bwidth%5D=1280/007f22a0-0153-11ef-a588-e798d47e404e-wegovy_novo_big.png)
![week 7 semaglutide Efficacy and safety of once weekly 24 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial semaglutide [TUSOM | Pharmwiki]](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1352284593583637)
![week 7 semaglutide Efficacy and safety of once weekly 24 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial semaglutide [TUSOM | Pharmwiki]](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=919588920996650)
